961 / 1119
SUMMARY
DURING AND EARLY AFTER TREATMENT
During
definitive
radio(chemo)therapy
with
IGABT,
the global health status / general QoL, physical and role functioning is
substantially impaired.
Although the functioning returns to patients’ baseline levels three
months after treatment, it remains markedly lower compared to an age
matched reference population.
The transient decrease in functioning is paralleled by a transient
increase in patient reported treatment-related symptoms, notably
fatigue syndrome, diarrhea, urinary frequency and nausea.
Kirchheiner et al. Gyn Oncol 2014